title: Fulminant hepatic failure associated with bicalutamide.
abstract: Bicalutamide is a new, nonsteroidal antiandrogen with a favorable toxicity profile. We report the first case of fulminant hepatic failure associated with its use.
authors.affiliation: Department of Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, University of Toronto, Ontario, Canada.
authors.forename: L A
authors.initials: LA
authors.lastname: Dawson
authors.forename: E
authors.initials: E
authors.lastname: Chow
authors.forename: G
authors.initials: G
authors.lastname: Morton
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000726:Androgen Antagonists / Q000009:adverse effects*; D000813:Anilides / Q000009:adverse effects*; D006501:Hepatic Encephalopathy / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014105:Tosyl Compounds
chemical_list: D000726:Androgen Antagonists; D000813:Anilides; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide